|
Chris leads the sales, professional services, legal and information technology infrastructure teams. Prior to his appointment as company COO, Chris served as Vice President of Operations and Business Development. Prior to Clinipace, Chris Porter served as Vice President of Corporate Development & Legal Affairs for Drug Safety Alliance, Inc. (DSA), with responsibility for sales, marketing, business development and legal affairs. While with DSA, he co-developed the corporate growth strategy, and helped establish DSA as the leading Drug Safety Management Organization in the US. Prior to DSA, Chris served as Group Manager of the Siebel Venture Group, Siebel Systems, Inc. where he was responsible for all of Siebel's venture transactions and management of a $30M portfolio with a specific interest in Life Science technology opportunities. Chris joined Siebel through Siebel's $542M acquisition of OpenSite Technologies where Chris was the original member of the business development group and worked with management and product marketing to develop and execute partnering strategy to support sales and marketing. Chris has held various other positions in the life science industry including positions in Sales and Marketing for Glaxo, Inc. and Quintiles Transnational, the world's largest CRO, and Manager of Legal & Business Affairs for AM Pappas & Associates, one of the largest life science venture capital firms in the Southeast. Chris received his Juris Doctor and Masters of Business Administration from the University of North Carolina at Chapel Hill in 1998. Chris also earned his BA in Journalism/Advertising from UNC-CH in 1992. | 